Home โ€บ Neuroscience โ€บ Better IHC Step 1: Antigen Retrieval
Steps
  1. 1 Understand antigen retrieval importance 00:04
  2. 2 Review antigen retrieval methods 01:03
  3. 3 Select heat-induced epitope retrieval 01:35
  4. 4 Optimize buffer pH for epitope recovery 01:54
  5. 5 Apply citrate buffer with PLK antibody 02:21
Neuroscience Cell Signaling Technology

Better IHC Step 1: Antigen Retrieval

Protocol
Difficulty
intermediate

Steps

1
Understand antigen retrieval importance

Learn why antigen retrieval is critical for successful immunohistochemistry. The narrator explains that proper buffer selection and pH control directly impact antibody-epitope binding and staining results.

โ–ถ 00:04
2
Review antigen retrieval methods

Identify two main approaches: proteolytic-induced antigen retrieval using enzymes like Proteinase K, and heat-induced epitope retrieval (HIER) that uses heat to denature crosslinks and expose antigens.

โ–ถ 01:03
3
Select heat-induced epitope retrieval

Choose heat-induced epitope retrieval as the standard method for antibody validation at Cell Signaling Technology. This technique involves heating and cooling tissue sections immersed in a buffered solution.

โ–ถ 01:35
4
Optimize buffer pH for epitope recovery

Adjust the pH of the buffer solution to maintain proper protein configuration as temperature returns to normal. Select slightly acidic citrate buffer for broad epitope recovery, or alkaline EDTA buffer for specific epitopes.

โ–ถ 01:54
5
Apply citrate buffer with PLK antibody

Use citrate buffer for heat-induced antigen retrieval while optimizing experimental conditions with rabbit PLK monoclonal antibody. Maintain this standard method while adjusting other auxiliary reagents in subsequent steps.

โ–ถ 02:21

๐Ÿšจ Failure Case Library (18) + Submit your own case

critical
False-Positive Signal from Endogenous Enzyme Activity
High background signal observed when using enzyme-conjugated antibodies (HRP or AP), caused by endogenous alkaline phosphatase or peroxidase activity in tissue generating false-positive results.
๐Ÿ’ก 4 ยท โœ“ 4
critical
Mouse-on-Mouse Cross-Reactivity in Tissue Staining
High background when using mouse primary antibodies on mouse tissue, caused by secondary antibody binding to endogenous mouse immunoglobulins and Fc receptors rather than only the primary antibody.
๐Ÿ’ก 4 ยท โœ“ 4
critical
Complete Absence of IHC Staining
Complete lack of staining observed in immunohistochemistry experiment despite using validated antibody. Tissue sections appear negative even when positive control should show signal.
๐Ÿ’ก 6 ยท โœ“ 6
severe
High Background from Insufficient Non-Specific Blocking
Diffuse background staining observed throughout tissue sections in IHC experiments, indicating inadequate blocking of non-specific antibody binding sites.
๐Ÿ’ก 4 ยท โœ“ 4
severe
Over-Amplified Signal with Biotin-Based Detection Systems
Excessive background staining when using amplification techniques or biotin-based detection, either from high signal amplification or endogenous biotin binding to streptavidin/avidin.
๐Ÿ’ก 4 ยท โœ“ 4
severe
Antibody not validated for IHC application or tissue type
Complete absence of staining with antibody that works in other applications. The antibody may not recognize native protein conformation present in tissue sections.
๐Ÿ’ก 4 ยท โœ“ 5
severe
Incorrect Antibody Diluent Selection
Suboptimal signal intensity or background issues despite correct antibody concentration. Different antibodies show dramatically different performance in TBST/5% NGS versus SignalStain Antibody Diluent.
๐Ÿ’ก 3 ยท โœ“ 3
severe
Formaldehyde fixation masked epitopes preventing antibody binding
No staining in formaldehyde-fixed tissues despite validated antibody. Fixation-induced protein crosslinking masks epitopes and prevents antibody recognition.
๐Ÿ’ก 4 ยท โœ“ 5
severe
Weak or Suboptimal IHC Staining Intensity
Staining signal is present but significantly weaker than expected, with poor contrast between positive cells and background, making interpretation difficult.
๐Ÿ’ก 5 ยท โœ“ 5
severe
Antigen Retrieval Method Not Optimized for Target
Staining results are inconsistent or suboptimal despite correct antibody and detection system, with signal strength varying significantly based on retrieval method used.
๐Ÿ’ก 4 ยท โœ“ 4
severe
Suboptimal Antigen Retrieval Method Selection
Weak or absent staining despite proper antibody concentration and incubation. Clear performance differences observed when comparing different antigen retrieval heating methods.
๐Ÿ’ก 4 ยท โœ“ 4
moderate
Non-Specific Binding from Elevated Incubation Temperature
Increased background staining when primary antibody incubation is performed at room temperature, as higher temperatures promote non-specific antibody-tissue interactions.
๐Ÿ’ก 4 ยท โœ“ 4
moderate
Edge Artifacts from Tissue Section Drying
Higher background staining concentrated at the edges of tissue sections compared to the center, indicating tissue dehydration during the staining procedure.
๐Ÿ’ก 4 ยท โœ“ 5
moderate
Weak or absent signal from inadequate antibody concentration or incubation
No detectable staining despite proper protocol execution. Insufficient antibody-antigen binding due to suboptimal concentration or incubation conditions.
๐Ÿ’ก 4 ยท โœ“ 5
moderate
Spotty or Uneven Background Staining Pattern
Staining pattern shows irregular, patchy, or spotty background with uneven distribution across tissue sections, indicating technical artifacts rather than biological variation.
๐Ÿ’ก 3 ยท โœ“ 3
moderate
High Background Staining in IHC
Excessive background signal obscuring specific staining. Non-specific binding observed throughout tissue sections, making interpretation difficult.
๐Ÿ’ก 5 ยท โœ“ 5
moderate
Edge effect / uneven staining across the slide
Slide edges show darker staining than center, or one half stains more than the other; reproducibility between fields is poor.
๐Ÿ’ก 4 ยท โœ“ 4
moderate
Loss of membrane protein staining after permeabilization
No staining is detected when targeting membrane proteins in IHC. Signal is absent despite antibody validation, suggesting structural damage to membrane epitopes.
๐Ÿ’ก 3 ยท โœ“ 4
๐Ÿ’ฌ Comments coming soon